Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

5.59USD
21 Sep 2018
Change (% chg)

$-0.15 (-2.61%)
Prev Close
$5.74
Open
$5.75
Day's High
$5.75
Day's Low
$5.38
Volume
2,624
Avg. Vol
2,792
52-wk High
$12.59
52-wk Low
$4.42

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Ronald Blanck

74 2011 Independent Chairman of the Board

Michael Jebsen

44 2018 President, Chief Financial Officer

Anthony DiTonno

69 2018 Chief Executive Officer, Director

Douglas Hay

2013 Executive Vice President - Regulatory Affairs

Doug Randall

2013 Executive Vice President - Business and Commercial Operations